Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:IRTC 9 January 2026 - 13 January 2026

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm Technologies shares dropped 7.5% to $156.24 Tuesday after the company announced 2026 sales targets and a restructuring plan during the J.P. Morgan Healthcare Conference. The company raised its 2025 revenue forecast above $740 million and projected 2026 revenue of $870–$880 million. iRhythm also created a new holding-company structure, effective Jan. 12, with no change to its ticker symbol.
13 January 2026
·
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

iRhythm shares fell 5.6% to $169.30 in late trading Monday after the company forecast 2026 revenue of $870–$880 million and an adjusted EBITDA margin of 11.5%–12.5%. Investors focused on the lack of detailed cost and margin data, as well as an upcoming corporate name change. About 1.35 million shares traded, with the stock swinging between $157.34 and $179.82. The company’s update remains preliminary.
12 January 2026
··

Stock Market Today

  • Evertz Technologies Fair Value Targets Lifted by Analysts on TSX
    March 20, 2026, 2:37 PM EDT. Analysts have raised the fair value estimate for Evertz Technologies (TSX:ET) from CA$14.88 to CA$17.25, reflecting a roughly 16% increase and aligning with a cluster of price targets between CA$16 and CA$17.50. Canaccord and BMO Capital have each lifted their price targets to CA$17.50, maintaining positive ratings, while RBC Capital has raised its target incrementally to CA$16 but retains a cautious Sector Perform stance. The upward revisions follow updated assumptions, including a slight dip in revenue growth to 4.16% and an improved net profit margin to 12.98%. The stock's quarterly dividend was declared at CA$0.2050 per share, payable March 2026. Investors should note the narrowed upside range and potential risks flagged, advising careful consideration of entry points and expectations.
Go toTop